13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 1,974,213 | $514,558,876 | +1087% | 0.37% |
| 2. | 1,675,500 | $436,702,320 | +66% | 0.07% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 1,545,600 | $402,845,184 | +97% | 0.93% |
| 4. | 1,214,800 | $316,625,472 | +16% | 0.05% | |
| 5. | Citadel Investment Group Ken Griffin | 524,503 | $136,706,462 | +6621% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | Director | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | Director | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | Officer, Director | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $292.84 | 8,711 | Officer | 71,546 | 2025-02-19 | Filing | |
| $304.44 | 25,225 | Officer | 36,922 | 2025-02-21 | Filing | |
| $293.22 | 8,711 | Officer | 62,147 | 2025-02-19 | Filing | |
| $293.74 | 1,524 | Officer | 8,544 | 2025-02-19 | Filing | |
| $292.56 | 500 | Officer | 8,544 | 2025-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,316 | $2,590,918 | 0.39% | |
| 2. | 6,549 | $2,040,341 | 0.06% | |
| 3. | 3,913 | $1,219,248 | 0.11% | |
| 4. | 1,873 | $583,534 | 0.02% | |
| 5. | 833 | $259,521 | 0.05% |
News See All
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Dobermans of the Dow: 10 Stocks to Consider
The Dobermans of the Dow strategy serves as an alternative to the well-known Dogs of the Dow approach, offering a more selective screening process.
11 Best Undervalued Stocks to Invest in Now
On March 5th, BBC reported that the US stock market had fallen after the tariffs sparked trade war fear.
18 AI News and Ratings Making Waves on Wall Street
In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI expert, Gary Marcus shared his perspective on the limitations of current AI models, the hurdles in enterprise adoption, and...
10 Best Vaccine Stocks to Buy According to Hedge Funds
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay ...
10 Best Retirement Stocks to Buy According to Hedge Funds
After much suspense, the US Federal Reserve finally began cutting interest rates in late 2024, dropping the federal funds rate by 75 basis points in two cuts in September and November, with the market...
11 Best Performing Dow Stocks So Far in 2025
As of 20 February 2025, the index has steadily increased, rising 14.41% in the last 12 months and 4.21% year to date in 2025.
10 Cheap Pharmaceutical Stocks to Buy According to Analysts
Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development of new medicines...